Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Glaucoma: Overview

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Barriers to eye donation in Aotearoa New Zealand: a novel qualitative analysis.

The New Zealand medical journal·2026

Same author

Keratitis after keratoplasty: risk modifiers, microbial resistance and outcomes in the COVID-19 era.

International ophthalmology·2025

Same author

Rates of eye donation amongst multi-organ donors over a decade (2013-2022) in new Zealand/Aotearoa.

Scientific reports·2025

Same author

The Impact of Gender, Ethnicity, and the COVID-19 Pandemic on Organ Donation Intentions Over 50 Years in New Zealand.

Clinical transplantation·2025

Same author

The Role of Ageing in the Clinical Presentation of Uveitis.

American journal of ophthalmology·2025

Same author

Provision of care for diabetic retinopathy in New Zealand: are there ethnic disparities?

The New Zealand medical journal·2024

Search research articles

Related Experiment Video

Updated: Jun 29, 2025

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

Uveitic Macular Edema: Clinical Outcomes in Real-World Practice.

Nazima Ali¹, Joanne Sims², Rachael Niederer²

¹Ophthalmology, Hospital Selayang, Batu Caves, Malaysia.

Ocular Immunology and Inflammation

|March 28, 2024

Summary

This study found that while uveitic cystoid macular edema (CME) has a high resolution rate, recurrence is common. Smoking cessation is crucial for reducing CME recurrence risk.

Keywords:

Anterior uveitis infectious uveitis treatment uveitic macular edema visual outcome

More Related Videos

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

Related Experiment Videos

Last Updated: Jun 29, 2025

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

Area of Science:

Ophthalmology
Inflammatory Eye Diseases
Retinal Disorders

Background:

Uveitic cystoid macular edema (CME) presents a significant challenge in clinical management due to diverse etiologies and variable therapeutic responses.
Understanding the real-world outcomes of uveitic CME is essential for optimizing patient care.

Purpose of the Study:

To investigate the clinical management strategies and outcomes, including resolution and recurrence rates, of uveitic cystoid macular edema (CME).

Main Methods:

A retrospective study analyzed data from 218 patients (248 eyes) diagnosed with uveitic CME from an Inflammatory Eye Disease database.
Key outcome measures included time to resolution, time to recurrence, and incidence of vision loss.

Main Results:

The overall resolution rate for uveitic CME was 85.3%. Intravitreal steroids demonstrated the highest resolution rate (86.7%).
Recurrence occurred in 36.5% of cases. Current smoking status (HR 1.818, p=0.042) and subretinal fluid at diagnosis (HR 1.577, p=0.043) were significant predictors of recurrence.
Infectious etiologies were associated with lower resolution rates but also a lower probability of recurrence once resolved.
Moderate (9.7%) and severe (6.9%) vision loss were observed.

Conclusions:

Uveitic CME management is complex, with a high resolution rate achievable over time, though recurrence affects over a third of patients.
Current smoking is a significant risk factor for CME recurrence, underscoring the importance of smoking cessation interventions.
Further research into heterogeneous etiologies and tailored treatment approaches is warranted.